Cannabis use, oral dysbiosis, and neurological disorders-Reference-Cited by-同舟云学术

Cannabis use, oral dysbiosis, and neurological disorders

Published:2024-08-09 Issue: Volume: Page:
ISSN:2750-6665
Container-title:NeuroImmune Pharmacology and Therapeutics
language:en
Short-container-title:

Author:

Hazzard Amber A.¹²,McCrorey Marice³,Salman Tabinda¹,Johnson Douglas E.¹²,Luo Zhenwu¹,Fu Xiaoyu¹,Keegan Andrew P.⁴,Benitez Andreana⁵,Fitting Sylvia⁶,Jiang Wei¹²⁷

Affiliation:

1. Department of Microbiology and Immunology , 2345 Medical University of South Carolina , Charleston , SC , USA

2. Ralph H. Johnson VA Medical Center , Charleston , SC , USA

3. Department of Molecular and Cellular Biology and Pathobiology , 2345 Medical University of South Carolina , Charleston , SC , USA

4. Division of Multiple Sclerosis and Neuroimmunology, Department of Neurology , 2345 Medical University of South Carolina , Charleston , SC , USA

5. Department of Neurology , 2345 Medical University of South Carolina , Charleston , SC , USA

6. Department of Psychology & Neuroscience , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA

7. Divison of Infectious Diseases, Department of Medicine , 2345 Medical University of South Carolina , Charleston , SC , USA

Abstract

Abstract Cannabis (marijuana) is a leafy plant that has medical, recreational, and other uses. Cannabis is socially accepted and widely used throughout the United States. Though cannabis use is increasingly gaining popularity, studies detail the deleterious effects of chronic cannabis smoking on mental health, as well as the immunosuppressive properties of cannabinoids. Additionally, oral dysbiosis induced by cannabis smoking serves as a novel catalyst for neurological abnormalities, potentially possible through microbial translocation via the oral-brain axis. This review summarizes the effects and link of smoking cannabis on neurological abnormalities, immunity, and oral microbiome.

Funder

Medical Research Service at the Ralph H. Johnson VA Medical Center

National Institute of General Medical Sciences

Intramural Research Program

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/nipt-2024-0012/pdf

Reference139 articles.

1. Russo, EB, Jiang, H-E, Li, X, Sutton, A, Carboni, A, del Bianco, F, et al.. Phytochemical and genetic analyses of ancient cannabis from Central Asia. J Exp Bot 2008;59:4171–82. https://doi.org/10.1093/jxb/ern260.

2. Piluzza, G, Delogu, G, Cabras, A, Marceddu, S, Bullitta, S. Differentiation between fiber and drug types of hemp (Cannabis sativa L.) from a collection of wild and domesticated accessions. Genet Resour Crop Evol 2013;60:2331–42. https://doi.org/10.1007/s10722-013-0001-5.

3. American Psychiatric Association, DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5TM, 5th ed. Arlington, VA: American Psychiatric Publishing, Inc.; 2013.

4. Hasin, DS, Saha, TD, Kerridge, BT, Goldstein, RB, Chou, SP, Zhang, H, et al.. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry 2015;72:1235–42. https://doi.org/10.1001/jamapsychiatry.2015.1858.

5. Legislatures NCoS. State medical cannabis laws: NCSL; 2023. Available from: https://www.ncsl.org/health/state-medical-cannabis-laws#Body.